University of Notre Dame du Lac’s Genomic Health, Inc. GHDX Stock Holding History

University of Notre Dame du Lac’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-12,063	Closed	-$818K	–	65
2019 Q3	$818K	Sell	12,063 -53,690	-82%	-$3.69M	0.24%	49
2019 Q2	$3.83M	Buy	65,753 +34,076	+108%	+$2.02M	0.87%	46
2019 Q1	$2.22M	Buy	31,677 +318	+1%	+$23.6K	0.5%	59
2018 Q4	$2.02M	Sell	31,359 -21,149	-40%	-$1.48M	0.49%	60
2018 Q3	$3.69M	Sell	52,508 -19,832	-27%	-$1.16M	0.69%	45
2018 Q2	$3.65M	Sell	72,340 -8,563	-11%	-$340K	0.71%	45
2018 Q1	$2.53M	Sell	80,903 -11,376	-12%	-$377K	0.47%	65
2017 Q4	$3.16M	Buy	92,279 +9,776	+12%	+$312K	0.65%	52
2017 Q3	$2.65M	Buy	82,503 +2,368	+3%	+$74.7K	0.74%	60
2017 Q2	$2.61M	Buy	80,135 +442	+0.6%	+$14K	0.77%	60
2017 Q1	$2.51M	Buy	+79,693	New	+$2.36M	0.63%	57

University of Notre Dame du Lac's GHDX Position: Q4 2019 in Review

University of Notre Dame du Lac sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 12,063 shares — an estimated $818K sold.

University of Notre Dame du Lac first reported a position in GHDX in Q1 2017 and held it in 11 quarters. The position peaked at $3.83M in Q2 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

University of Notre Dame du Lac reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
University of Notre Dame du Lac sold 12,063 Genomic Health, Inc. shares in Q4 2019, an estimated $818K.
University of Notre Dame du Lac first reported a position in Genomic Health, Inc. in Q1 2017 and held it in 11 quarters.
University of Notre Dame du Lac's Genomic Health, Inc. position peaked at $3.83M in Q2 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on University of Notre Dame du Lac's 13F filing for Q4 2019, filed 14 Feb 2020.